...
GLPGMID

Galapagos N.V.

HealthcareBiotechnology
$33.66
$0.00(+0.51%)
52W$22.59
$37.78
FinancialsValuationvs ARGX
Updated Mar 2, 12:00 AM
RSI46
RS Rating60/99
Beta0.41
Volatility29%
F-Score5/9
Mkt Cap$2.2B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Galapagos N.V. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 60), indicating performance broadly in line with the market. Earnings growth of 40% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
60
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.41
vs S&P 500
LOW VOL
52W Position
73%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$33.54
50 SMA > 100 SMA$32.74
100 SMA > 150 SMA$32.78
150 SMA > 200 SMA$31.84

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$33.94-0.81%BELOW
50 SMA$33.54+0.35%ABOVE
100 SMA$32.74+2.82%ABOVE
150 SMA$32.78+2.67%ABOVE
200 SMA$31.84+5.70%ABOVE

Price Performance

1D+0.5%
1W-0.6%
1M-1.3%
3M+7.5%
6M+3.9%
YTD+2.1%
1Y+29.1%
3Y-3.5%
52-Week Trading Range73% from low
$33.66
52W Low$22.59
52W High$37.78

Technical Indicators

RSI (14)NEUTRAL
46.4
305070
VCP ScoreWARM
6/10
Base depth: 15.5%

Risk Profile

Beta
0.41
52W Vol
29%
ATR
$0.76
Max DD (1Y)
-21%

Volume Analysis

Today
33
50D Avg
88.3K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-270%
$-2.33
Q2'25-1250%
$-1.61
Q3'25-319%
$-3.10
Q4'25+3955%
$11.76
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+39.60%
5 Years:+18.40%
3 Years:+66.43%
TTM:+303.48%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+345.28%

Stock Price CAGR

10 Years:-1.96%
5 Years:-16.84%
3 Years:-3.52%
1 Year:+29.06%

Return on Equity

10Y Avg:-0.2%
5Y Avg:1.6%
3Y Avg:7.0%
Last Year:9.9%

Key Metrics

Market Cap$2.2B
Gross Margin56.0%
Net Margin28.9%
Piotroski F-Score5/9

More GLPG Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

GLPG vs ARGXARGXCANFAKTXABVX

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 60 meansGLPG outperformed 60% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.41 means 59% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 5/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is GLPG in an uptrend right now?

GLPG has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is GLPG overbought or oversold?

GLPG's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.

Is GLPG outperforming the market?

GLPG has a Relative Strength (RS) Rating of 60 out of 99. GLPG is performing about average compared to the market.

Where is GLPG in its 52-week range?

GLPG is trading at $33.66, which is 89% of its 52-week high ($37.78) and 73% above its 52-week low ($22.59).

How volatile is GLPG?

GLPG has a Beta of 0.41 and 52-week volatility of 29%. It's less volatile than the S&P 500 - generally more stable.